In 140 patients with cirrhosis and community-acquired spontaneous bacterial peritonitis, cefoxitin vs cefotaxime gave similar Day 5 clinical response (74.3% vs 71.4%, P=0.704). Hepatorenal syndrome (8.6% vs 7.1%) and mortality (12.9% vs 15.7%) did not differ significantly.
RCTn = 140
Ebrahim et al. Cefoxitin versus cefotaxime as empirical treatment of spontaneous bacterial peritonitis in liver cirrhotic patients: randomized controlled clinical trial